Qiang Zhou
Direttore/Membro del Consiglio presso Taizhou EOC Pharma Co., Ltd.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Xiao Ming Zou | M | 57 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China.
Tsinghua University
| 19 anni |
Xu Jing Su | M | 41 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 5 anni |
Wu Xiang Zhu | M | 59 |
Tsinghua University
| 41 anni |
Qing Xu | M | 53 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 4 anni |
Xin Ni | M | 53 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 14 anni |
Huan Yang | M | 41 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 5 anni |
Hong Yan Wang | F | 57 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 4 anni |
He Ting Li | M | 49 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 12 anni |
Robert G. L. Shorr | M | 71 |
Stony Brook University
| 26 anni |
Wen Kong | M | 57 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 6 anni |
Ting Fu | F | 32 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 5 anni |
Miao Jie Chen | F | 41 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 7 anni |
Song Zhou | M | 43 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 5 anni |
Cui Ping Gu | M | 44 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 7 anni |
Jing Yan Song | M | 60 |
Tsinghua University
| 36 anni |
Jian Chen | M | 62 |
Tsinghua University
| 35 anni |
Zheng Yao | F | 40 |
Taizhou EOC Pharma Co., Ltd.
Taizhou EOC Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Taizhou EOC Pharma Co., Ltd. engages in the research and development, and sale of drugs for tumor treatment. Its business segments include clinical trial research, pharmaceutical production, drug discovery and product introduction, drug registration, and product sales and commercialization. Its Clinical Trial Research segment involves in the clinical plan formulation, patient inclusion and exclusion criteria design, and primary and secondary endpoint indicators selection. Its Pharmaceutical Production segment supplies entinostat clinical trial drugs. Its Drug Discovery and Product Introduction segment implements drug discovery and research. Its Drug Registration segment manages product registration with drug regulatory department. Its Product Sales and Commercialization segment offers pharmaceutical academic promotion and sales agency assistance for pharmaceutical companies. The company was founded by Xin Ni and Xiao Ming Zou on October 21, 2010 and is headquartered in Taizhou, China. | 5 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Ji Sheng Li | M | 59 |
Tsinghua University
| 9 anni |
Hong Bin Sun | M | 55 |
Tsinghua University
| 10 anni |
Feng Deng | M | 61 |
Tsinghua University
| 6 anni |
Yu Zhang | F | 58 |
Tsinghua University
| 4 anni |
Feng Li | M | 56 |
Tsinghua University
| 5 anni |
Shi Bin Gao | M | 60 |
Tsinghua University
| 6 anni |
Zhi He Meng | M | 69 |
Tsinghua University
| 7 anni |
Jian Cun Gao | M | 62 |
Tsinghua University
| 7 anni |
Xiao Bo Ge | M | 53 |
Tsinghua University
| 7 anni |
Qi Ning | M | 60 |
Tsinghua University
| 6 anni |
Xiao Qiang Cai | M | 63 |
Tsinghua University
| 4 anni |
Helen Remeza | M | - |
Tsinghua University
| 6 anni |
Tracy Rice | F | - |
Stony Brook University
| 6 anni |
Mark Gorman | M | - |
University of Pittsburgh
| 3 anni |
Xiao Jun Fan | M | 58 |
Tsinghua University
| 6 anni |
Dong Yi Jiang | M | 59 |
Tsinghua University
| 6 anni |
Wei Zhen Sun | M | 61 |
Tsinghua University
| 7 anni |
Xiaoyan Li | M | 61 |
Tsinghua University
| 6 anni |
Xun He | M | 60 |
Tsinghua University
| 6 anni |
Jun Yu Chen | M | 58 |
Tsinghua University
| 6 anni |
Genshu Zhou | M | 60 |
Tsinghua University
| 6 anni |
Ai Ming Liu | M | 55 |
Tsinghua University
| 6 anni |
Shao Ming Guo | M | 59 |
Tsinghua University
| 6 anni |
Dong Ping Luo | M | 59 |
Tsinghua University
| 6 anni |
Zheng Shi | M | 57 |
Tsinghua University
| 6 anni |
Dennis G. Prado | M | - |
University of Pittsburgh
| 2 anni |
Yong Zhao | M | 61 |
Tsinghua University
| 10 anni |
Wenmao Long | M | 56 |
Tsinghua University
| 8 anni |
Lin-Feng Li | M | - |
Tsinghua University
| 6 anni |
Li Zhuang | M | - |
Tsinghua University
| 6 anni |
Liji Huang | M | - |
Tsinghua University
| 7 anni |
Ren Dong Wu | M | 52 |
Tsinghua University
| 5 anni |
Zhibin Miao | M | 54 |
Tsinghua University
| 4 anni |
Wei Feng | M | 45 |
Tsinghua University
| 4 anni |
Feng Wei Zhang | M | - |
Tsinghua University
| 4 anni |
Yan Feng Zhang | M | 54 |
Tsinghua University
| 4 anni |
Guo Min Chen | M | 57 |
Tsinghua University
| 3 anni |
Qin Si Zhao | M | 60 |
Tsinghua University
| 3 anni |
Li Chen | M | - |
Tsinghua University
| 5 anni |
Bin Dai | M | 60 |
Tsinghua University
| 4 anni |
Zhihua Jiang | F | 53 |
Tsinghua University
| 4 anni |
Mei Ying Zhu | M | 59 |
Tsinghua University
| 4 anni |
Jianxiang Chen | M | 53 |
Tsinghua University
| 4 anni |
Karl Zhao | M | 58 |
Tsinghua University
| 4 anni |
Li Hong Guo | F | 59 |
Tsinghua University
| 4 anni |
Geying Dai | M | 55 |
Tsinghua University
| 4 anni |
Tian Lei | M | 59 |
Tsinghua University
| 4 anni |
Li Jun Li | M | 52 |
Tsinghua University
| 4 anni |
Huyue Zhang | M | 53 |
Tsinghua University
| 4 anni |
Goetz Bendele | M | 54 |
Stony Brook University
| 3 anni |
Wei Zhong Qin | M | 52 |
Tsinghua University
| 4 anni |
Yan Bao Peng | M | 57 |
Tsinghua University
| 4 anni |
Hong Bo Lu | M | 53 |
Tsinghua University
| 4 anni |
Alice Cui | F | - |
Tsinghua University
| 5 anni |
Ping Jia | M | - |
Tsinghua University
| 4 anni |
Ching Wong | M | 59 |
Tsinghua University
| 3 anni |
Yi Yi Feng | M | 57 |
Tsinghua University
| 4 anni |
Yigong Shi | M | 57 |
Tsinghua University
| 4 anni |
Yu Feng Chi | M | 53 |
Tsinghua University
| 4 anni |
Jun Li | M | - |
Tsinghua University
| 5 anni |
Yuan Qiang Guo | M | 58 |
Tsinghua University
| 4 anni |
Jian Tong | M | - |
Tsinghua University
| 4 anni |
Qi Wu Xuan | M | 58 |
Tsinghua University
| 4 anni |
Yong Wu | M | 58 |
Tsinghua University
| 4 anni |
Zhen Jie Han | M | 55 |
Tsinghua University
| 4 anni |
Yu Qing Weng | M | 84 |
Tsinghua University
| - |
Hui Ning Zhang | M | 60 |
Tsinghua University
| 4 anni |
Ji Wen Zhang | M | 57 |
Tsinghua University
| 4 anni |
Jun Mo | M | 57 |
Tsinghua University
| 4 anni |
Shao Bo Wu | M | - |
Tsinghua University
| 4 anni |
Feng Ling Li | M | 75 |
Tsinghua University
| 1 anni |
Hong Xiao | M | 57 |
Tsinghua University
| 4 anni |
Li Ye Zhou | M | 61 |
Tsinghua University
| 1 anni |
Sheng Lin Ben | M | 58 |
Tsinghua University
| 4 anni |
Quan Fu | M | 61 |
Tsinghua University
| 4 anni |
Yongcun Chen | M | 59 |
Tsinghua University
| 4 anni |
Chang Yu Sun | M | 54 |
Tsinghua University
| 4 anni |
Jian Bin Luo | M | 60 |
Tsinghua University
| 4 anni |
Hong Yu Xing | M | 53 |
Tsinghua University
| 1 anni |
Bo Yang Liu | M | 54 |
Tsinghua University
| 4 anni |
Afzal M. Tarar | M | - |
Tsinghua University
| 5 anni |
Si Qing Peng | M | 58 |
Tsinghua University
| 5 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Cina | 94 | 94.95% |
Stati Uniti | 5 | 5.05% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Qiang Zhou
- Contatti personali